Avid Bioservices Inc. (CDMO)
undefined
undefined%
At close: undefined
12.34
0.04%
After-hours Dec 13, 2024, 04:15 PM EST

Company Description

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture.

The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support.

It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization.

The company serves biotechnology and biopharmaceutical industries.

The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018.

Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Avid Bioservices Inc.
Avid Bioservices Inc. logo
Country United States
IPO Date Apr 4, 1994
Industry Biotechnology
Sector Healthcare
Employees 371
CEO Nicholas Stewart Green B.Sc., MBA

Contact Details

Address:
2642 Michelle Drive
Tustin, California
United States
Website https://www.avidbio.com

Stock Details

Ticker Symbol CDMO
Exchange NASDAQ
Fiscal Year May - April
Reporting Currency USD
CIK Code 0000704562
CUSIP Number 05368M106
ISIN Number US05368M1062
Employer ID 95-3698422
SIC Code 2834

Key Executives

Name Position
Nicholas Stewart Green B.Sc., MBA President, Chief Executive Officer & Director
Daniel R. Hart Chief Financial Officer
Mark R. Ziebell J.D. Vice President, General Counsel & Corporate Secretary
Matthew R. Kwietniak Chief Commercial Officer
Richard A. Richieri Chief Operations Officer

Latest SEC Filings

Date Type Title
Dec 13, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Dec 10, 2024 10-Q Quarterly Report
Dec 10, 2024 8-K Current Report
Dec 03, 2024 PREM14A Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 07, 2024 DEFA14A Filing
Nov 07, 2024 DEFA14A Filing
Nov 07, 2024 8-K Current Report
Oct 17, 2024 8-K Current Report